SeaTown Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,000
Closed -$1.08M 62
2023
Q1
$1.08M Hold
5,000
0.15% 51
2022
Q4
$1.1M Hold
5,000
0.16% 56
2022
Q3
$674K Hold
5,000
0.1% 57
2022
Q2
$809K Hold
5,000
0.18% 42
2022
Q1
$943K Hold
5,000
0.07% 73
2021
Q4
$1.35M Buy
+5,000
New +$1.69M 0.07% 76
2018
Q2
Sell
-20,000
Closed -$3.36M 62
2018
Q1
$3.36M Buy
+20,000
New +$2.71M 0.32% 53

Other funds holding ONC

SeaTown Holdings's ONC Position: Q2 2023 in Review

SeaTown Holdings sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 5,000 shares — an estimated $1.08M sold.

SeaTown Holdings first reported a position in ONC in Q1 2018 and held it in 7 quarters. The position peaked at $3.36M in Q1 2018. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • SeaTown Holdings reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • SeaTown Holdings sold 5,000 BeOne Medicines Ltd shares in Q2 2023, an estimated $1.08M.
  • SeaTown Holdings first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 7 quarters.
  • SeaTown Holdings's BeOne Medicines Ltd position peaked at $3.36M in Q1 2018.
  • 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on SeaTown Holdings's 13F filing for Q2 2023, filed 2 Aug 2023.